Viral Sensing at the Blood–Brain Barrier: New Roles for Innate Immunity at the CNS Vasculature

B. P. Daniels, R. S. Klein

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Abstract

Neurotropic viral infections are a major source of disease worldwide and represent a growing burden to public health. While the central nervous system (CNS) is normally protected from viral infection by the blood–brain barrier (BBB), many viruses are able to cross the BBB and establish CNS infection through processes that largely remain poorly understood. A growing body of recent research has begun to shed light on the viral and host factors that modulate BBB function, contributing to both protective and pathological disease processes. Central to these studies have been the actions of host cytokines and chemokines, which have increasingly been shown to be key regulators of BBB physiology. This review summarizes recent advances in understanding how BBB function governs both viral pathogenesis and host immune responses during neurotropic viral infections.

Original languageEnglish
Pages (from-to)372-379
Number of pages8
JournalClinical pharmacology and therapeutics
Volume97
Issue number4
DOIs
StatePublished - Apr 2015

Fingerprint

Dive into the research topics of 'Viral Sensing at the Blood–Brain Barrier: New Roles for Innate Immunity at the CNS Vasculature'. Together they form a unique fingerprint.

Cite this